Clinical Trial Update: TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating transarterial chemoembolization (TACE) with or without radiation therapy for stage I–III hepatocellular carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Adult Primary Hepatocellular Carcinoma, Recurrent Adult Primary Liver Cancer | Phase 2 | Status: WITHDRAWN